对肺癌的进展,丹麦,2008年至2022年
Marianne Steding-Jessen1, Henriette Engberg2, Erik Jakobsen3
1The Danish Clinical Quality Program and Clinical Registries (RKKP), Aarhus, Denmark. masted@rkkp.dk.
Acta oncologica (Stockholm, Sweden)
|May 15, 2024
概括
丹麦的肺癌存活率和死亡率有所改善,原因是晚期诊断较少,各个阶段治疗结果更好. 这一进展反映了肺癌管理方面的重大进展.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 丹麦在打击肺癌方面取得了重大进展.
- 了解这些改进的驱动因素对于未来的战略至关重要.
研究的目的:
- 调查丹麦肺癌的特定阶段发病率,存活率和死亡率.
- 分析趋势并确定有助于改善肺癌结果的因素.
主要方法:
- 利用来自丹麦肺癌登记处的数据来确定诊断日期和临床阶段.
- 按性别,时期和阶段计算的年龄标准化发病率和生存率.
- 从丹麦卫生数据管理局提取了肺癌特定死亡率数据.
主要成果:
- 发病率下降,主要是由于晚期诊断的减少.
- 患者的生存率在所有疾病阶段均呈现逐渐增加.
- 在研究期间,年龄标准化肺癌特定死亡率稳步下降.
结论:
- 肺癌存活率和死亡率的改善归因于晚期疾病发病率的减少.
- 肺癌各个阶段的生存率提高,有助于改善患者的治疗结果.
- 这些发现突显了当前战略的有效性,并为未来的公共卫生干预提供了信息.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Statistical Methods for Analyzing Epidemiological Data
363
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
363
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


